ResearchDx offers expertise as an integrated start-to-finish partner for IVD Development. With cost effective, risk mitigated solutions and clear strategic guidance, we simplify, accelerate, and ensure delivery of your FDA-approved companion diagnostics on time.
From Next Generation Sequencing, qPCR to ELISA, IHC and Flow, we bring you the BEST solution to fit your needs.
ResearchDx would like to welcome Martin Sellers as Vice President of Regulatory Affairs! Sellers’s history has included entrepreneurial ambitions that have brought a record of success in medical device and biotechnology products commercialization. He specialized in bringing novel healthcare products to market in a cost-effective manner, insuring long term profitability upon commercialization for management, investors, […]
Read MoreResearch Dx is pleased to announce two new additions to the senior management team. Stephen Jones as Chief Operating Officer and Tom Li as VP Business Development. Stephen Jones Chief Operating Officer Steve Jones is the COO for ResearchDx responsible for end-to-end oversight of all functions including laboratory operations, business development and research and development. Prior […]
Read More
